The Associated Press Has Quietly Come Around on a Drug It Once Used to Scorch Ron DeSantis

Seems the Associated Press would have reported on this development after it took a hard line against its promotion.

By Brad Slager Dec 21, 2021  

There seems to be a side-effect emerging from the new outbreak of the Omicron variant this winter. You may have experienced dizziness, confusion, or bouts of speechlessness – not from this COVID strain, but from the radical 180-degree shift experienced in the press. Suddenly, we see journalists saying things that mere months ago were grounds for de-platforming, or possibly being rounded up and placed in state custody, like a Down Under lock up.

Seemingly overnight and barely a week since Twitter forbade such discourse members of the press were freely commenting how people who were double-vaxxed and even boosted could contract COVID. Then we saw Brian Stelter, of all people, come out and push for kids to go back to school by saying things such as, "Shouldn't we be doing more to protect children by letting them live normal lives? Or, to pose the Q another way, are we really going to close schools again and let kids suffer even more?" Ron DeSantis was basically called a child-killer last summer when he said the very same type of things.

And on the subject of Florida's governor, the Associated Press had a curious report about the Omicron surge. In detailing what may lie ahead, the news syndicate indicated how the new strain could render some existing treatments as ineffective in battling the virus. Omicron may sideline two leading drugs against COVID-19, touts the headline. That word leading is what jumps out here, considering the drugs being covered. Next, there is this quote.

For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital.

This is a deeply curious development. Because four months ago, this same news outlet had taken Governor Ron DeSantis to task for his promoting Regeneron as a treatment for those who contract COVID. That article suggested the main reason he was pushing so hard for it was that a hedge fund with heavy investments in the drugmaker was a campaign donor. The wheels came off of this report in short order.